-+ 0.00%
-+ 0.00%
-+ 0.00%

4D Molecular Therapeutics announces annual shareholder meeting

PUBT·04/28/2026 20:15:23
Listen to the news
4D Molecular Therapeutics announces annual shareholder meeting
  • 4D Molecular Therapeutics scheduled 2026 annual stockholders meeting for June 17, 2026, to be held online.
  • Shareholders will vote on election of three Class III directors to terms running through 2029.
  • Ballot also covers ratification of PricewaterhouseCoopers as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
  • Advisory vote planned on compensation for named executive officers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-017427), on April 28, 2026, and is solely responsible for the information contained therein.